Literature DB >> 18159775

Examining the decay of HIV risk reduction outcomes following a community-friendly intervention targeting injection drug users in treatment.

Michael M Copenhaver1, I-Ching Lee.   

Abstract

It has become crucial for risk reduction interventions targeting injection drug users (IDUs) in treatment to be "community-friendly" and potent over time so that limited resources may be optimally utilized. This study examined (1) the extent to which observed post-intervention effects--including enhanced HIV-related knowledge, motivation, behavioral skills, and drug- and sex-risk reduction behavior--decayed over time and (2) whether repeating the intervention atfollow-up provided additional benefit. Approximately 10 months after completing an adapted, substantially shortened, version of an evidence-based intervention, participants completed a follow-up assessment and then repeated the intervention. No evidence of decay was found. Even so, after repeating the intervention, a trend toward additional sex-risk reduction was observed for participants at higher risk for HIV. Findings point to the potential for an adapted evidence-based intervention for IDUs to be both community-friendly and potent over time within community-based treatment settings.

Entities:  

Mesh:

Year:  2007        PMID: 18159775     DOI: 10.1080/02791072.2007.10400608

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  2 in total

1.  Change in Risk Perceptions and Marijuana and Cigarette Use Among African American Young Adult Females in an HIV Prevention Intervention.

Authors:  Sarah J Javier; Jasmine A Abrams; Melanie P Moore; Faye Z Belgrave
Journal:  J Racial Ethn Health Disparities       Date:  2016-12-06

Review 2.  A systematic review of recent smartphone, Internet and Web 2.0 interventions to address the HIV continuum of care.

Authors:  Kathryn E Muessig; Manali Nekkanti; Jose Bauermeister; Sheana Bull; Lisa B Hightow-Weidman
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.